Related Experiment Video
Updated: Jun 16, 2026

07:54
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Understanding pain in malignant mesothelioma: a prospective, longitudinal cohort study
Catriona R Mayland1,2, Michelle Collinson3, Sam H Ahmedzai4
1Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. c.r.mayland@sheffield.ac.uk.
BMC Palliative Care
|June 13, 2026
Summary
Malignant mesothelioma patients with moderate to severe pain had poorer quality of life and did not receive strong opioids. Early identification of high-risk patients is crucial for timely pain management strategies.
Area of Science:
- Oncology
- Palliative Care
- Pain Management
Background:
- Malignant mesothelioma pain is complex and its natural course is understudied.
- Understanding mesothelioma pain trajectory is vital for patient care.
- This study aimed to explore pain prevalence, severity, impact, and clinical course over 12 months.
Purpose of the Study:
- To investigate the prevalence, severity, and impact of pain in mesothelioma patients.
- To describe the clinical course of pain over a 12-month period.
- To correlate pain with quality of life and mood in mesothelioma patients.
Main Methods:
- A prospective observational study involving 150 newly diagnosed adult mesothelioma patients.
- Data collected included demographics, clinical data, pain characteristics (frequency, severity, impact), quality of life (EORTC QLQ-C15-PAL), and mood (Brief Pain Inventory).
- Follow-up was conducted quarterly for 12 months.
Main Results:
- 14.0% of participants reported moderate to severe chest pain, with none receiving strong opioids.
- Moderate to severe pain was associated with poorer quality of life and greater interference with daily activities.
- 44.0% of participants died within the 12-month follow-up period.
Conclusions:
- Patients with moderate to severe mesothelioma pain experience significantly worse quality of life.
- There is a need for early identification of high-risk patients to implement timely pain management.
- Future research should focus on optimizing breathlessness assessment and management, alongside severe pain in mesothelioma.

